Clark R W, Schmidt H S, Sotos J F
South Med J. 1978 Dec;71(12):1567-8. doi: 10.1097/00007611-197812000-00033.
We have described a 13-year-old white boy with Ondine's curse, sleep apnea and cataplexy who simultaneously developed progressive hypothalamic neuroendocrine deficiencies requiring replacement therapy. The patient was treated with protriptyline, a nonsedating tricyclic antidepressant, for control of the sleep-related symptoms. An unexpected result was the apparent reversal of his chronic diabetes insipidus by protriptyline, necessitating discontinuation of lysine-vasopressin. Some possible mechanisms of action were discussed.
我们描述了一名13岁患有奥狄氏征、睡眠呼吸暂停和发作性睡病的白人男孩,他同时出现了进行性下丘脑神经内分泌缺陷,需要替代治疗。该患者接受了普罗替林治疗,这是一种非镇静性三环类抗抑郁药,用于控制与睡眠相关的症状。一个意外的结果是普罗替林明显逆转了他的慢性尿崩症,因此必须停用赖氨酸加压素。文中讨论了一些可能的作用机制。